Newcastle United have signed Brentford striker Yoane Wissa after completing a £55 million ($74.4m) deal, the club announced after Monday's deadline.
Wissa, who underwent a Newcastle medical on Monday, will be tasked with replacing Alexander Isak, who completed his move to Liverpool.
Newcastle will receive around £125m as part of the Isak deal, and they re-invested a similar amount in his replacements, adding Germany forward Nick Woltemade from Stuggart in a £64.9m move.
The North East club had interest in Wolves forward Jørgen Strand Larsen, but sources told ESPN they decided not to pursue him while they chase Wissa's signature.
Wissa, 28, has not played for Brentford this season since demanding that the club allow him to move to Newcastle during preseason.
- LIVE BLOG: Follow the latest on transfer deadline day
- Men's grades: How we've rated the PL deals
- The completed transfers from the major football leagues
After seeing former Brentford teammate Bryan Mbeumo leave the Gtech Stadium for Manchester United earlier this summer, Wissa told the club that he also expected to be allowed to leave.
And after a lengthy stand-off, Brentford gave the player the green light to move to St. James' Park.
Information from ESPN's James Olley was used in this report.
Newer articles
Older articles
Gavaskar Calls for Kuldeep Yadav's Inclusion in 2nd Test Amid Bumrah Fitness Concerns, Cites Birmingham Pitch Conditions
Stokes Praises England Openers' Key Role in Record-Breaking Chase Against India
Black Caps Set for Blockbuster Home Summer Against Cricket Heavyweights: Australia, England, West Indies, and South Africa to Tour New Zealand
5 Warning Signs of Prediabetes You Might Be Missing
Former Selector Blasts India's Fielding Lapses After Test Defeat to England; 'Simple Catches Cost Us'
Nitish Rana Set for Delhi Comeback After Disappointing Uttar Pradesh Spell
Ederson Exits Man City for Fenerbahce, Paving the Way for Donnarumma's Etihad Arrival
Gambhir Stands by India's Lower Order Despite Test Collapse; Cites Missed Catches as Key Factor
India's First Dengue Vaccine: Phase 3 Trials Approach Finish Line, Promising Hope Against Deadly Virus
Rishabh Pant's Unorthodox Batting Revolutionizing Cricket, Claims Greg Chappell